Cases & Deals

AstraZeneca prosecutes worldwide patent portfolio licensed from Nektar Therapeutics

Clients AstraZeneca LP

Jones Day assisted AstraZeneca LP in worldwide patent prosecution and portfolio management of a patent portfolio licensed from Nektar Therapeutics covering compounds for treating opioid-induced constipation.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.